Intravenous Labetalol Usage among Hypertensive Pregnant Women Admitted to a Tertiary Care Hospital : A Prospective Observational Study

Authors

  • Rabinarayan Dash BBMCH, Balangir
  • Snehadarsini Karnath Indira IVF, JP Nagar Bangalore
  • Sushree Priyadarsini Satapathy BBMCH, Balangir 

DOI:

https://doi.org/10.37506/75cae353

Keywords:

Hypertension , Labetalol ,Pre-Eclampsia, Pregnancy, SBP, Severe.

Abstract

Abstract: Background: Hypertensive disorders complicating pregnancy are one of the deadly triad. Objectives :1) To assess the efficacy of intravenous (IV) labetalol in severe hypertension of pregnancy. 2) Determine the various adverse effects of IV labetalol on mother. 3) To find out the Foetal outcome to the use of IV Labetalol in the study group. Materials & Methods- It was a prospective observational study which was conducted for a period of 1 year among the Pregnant women. Total sample size was 100. Results: The rate of fall of systolic and Diastolic blood pressure occurred during first 40 min for drug. It is apparent that the target SBP & DBP was reached by the study groups in less than 20 minutes. Out of 100 cases only 14 patients had adverse effects . 94 were live,6 stillborn. Out of 94 live born babies 5(5.3%) had asphyxia, 4(4.3%) had HIE, 2(2.1%) were IUGR and 6(6.4%) were preterm. Conclusions- We found that labetalol regimen is highly effective & can safely be used due to its rapid onset of action, no significant adverse reaction and no adverse effects on foetus.

Author Biographies

  • Rabinarayan Dash, BBMCH, Balangir

    Assistant Professor, Dept O& G, BBMCH, Balangir

  • Snehadarsini Karnath, Indira IVF, JP Nagar Bangalore

    Reproductive Medicine Specialist,  Indira IVF, JP Nagar Bangalore

  • Sushree Priyadarsini Satapathy, BBMCH, Balangir 

    Assistant Professor , Dept Community Medicine, BBMCH, Balangir 

References

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Pregnancy Hypertension. Text Book of Williams Obstetrics. 23rd Edition.2010 New York, McGraw Hill. 706-757.

Mathew R, Devanesan B P, Srijana, Sreedevi N S. Prevalence of hypertensive disorders of pregnancy, associated factors and pregnancy complications in a primigravida population. Gynecology and Obstetrics Clinical Medicine 3 (2023):119–123.

National Collaborating Centre for Women's and Children's Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010 Aug.

Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol. 2003 Feb;101(2):289-96.

Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM,et al;. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006 Mar;194(3):639-49.

Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987 Sep;70(3 Pt 1):328-33.

Murty O K, Dhananjaya BS, Jamuna R,Chaitra R. Intravenous Labetalol in management of Hypertensive Emergencies in Pregnancy. Indian Journal of Obstetrics and Gynecology Research 2016;3(4):352-355.

Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomized trial. BJOG. 2012 Jan;119(1):78-85.

Ashe RG, Moodley J, Richards AM, Philpott RH. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. S Afr Med J. 1987 Mar 21;71(6):354-6.

Michael CA.Use of Labetalol in the treatment of severe hypertension during pregnancy. Br J Clin Pharmacol. 1979; 8(Suppl 2): 211S–215S.

Scardo JA, Vermillion ST, Hogg BB, Newman RB. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. Am J Obstet Gynecol. 1996 Aug;175(2):336-8.

Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I. Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. Eur J Obstet Gynecol Reprod Biol. 1992 Jun 16;45(1):47-51.

Lardoux H, Gerard J, Blazquez G, Chouty F, Flouvat B. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol. Eur Heart J. 1983 Nov;4 Suppl G:35-40.

Naden RP, Redman CW. Antihypertensive drugs in pregnancy. Clin Perinatol. 1985 Oct;12(3):521-38.

Verma R, Lahon K, Tonpay SD, Kale VJ, Jain DK. A comparative randomised controlled parallel group study of efficacy and tolerability of labetalol versus methyldopa in the treatment of new onset hypertension during pregnancy. Int J Life Sci Pharm Res. 2012;2(1):L23-31.

el-Qarmalawi AM, Morsy AH, al-Fadly A, Obeid A, Hashem M. Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension. Int J Gynaecol Obstet. 1995 May;49(2):125-30.

Lamming GD, Symonds EB. Use of labetalol and methyldopa in pregnancy-induced hypertension. Br J Clin Pharmacol. 1979 Apr;8 Suppl 2:217S-22S.

Downloads

Published

2025-01-07

How to Cite

Intravenous Labetalol Usage among Hypertensive Pregnant Women Admitted to a Tertiary Care Hospital : A Prospective Observational Study. (2025). Indian Journal of Public Health Research & Development, 16(1), 341-347. https://doi.org/10.37506/75cae353